- j- -I- REVTE~W 672 C T. F I D 7 i A Subiect ref 8d "Association between exposure to environmental tobacco smoke and exacerbations of asthma in children" R A Chilmonczyk et al New England Journal of Medicine (1993), 228. 1665-1669 lu In this study, conducted in a large allergy-asthma practice in Portland, Maine, USA, in 1992,data for 199 children aged up to 12 with asthma were collected on: (a) smoking by the parent and other members of the household (pro-.-ided by the parent), (b) cotinine (from urine provided by the child), (c) number of acute exacerbations of asthma in the last 12 months (from blind review of medical records), (d) lung function (from tests conducted on 145 of the 199 children), (e) demographic and other variables - including parental occupation and education, number of household members, age at diagnosis of asthma, child's current medication status, child's school status, and use of day care (provided by the parent), and (f) theophylline (from serum provided by 63 children) U1 As expected, there was a strong relationship between urinary C) cotinine (ad'usted for creatinine) and exposure to ETS, *.:,--.h median CD C7% co BATCo document for Legal Services : Health Canada 19 October 1999 levels 5.6 r.F,/ml if no hous ehold member smoked, ng/mI if mother or other household member~s) smoked, and 55.8 ng/ml if the mother and other household member(s) smoked. Using 10 ng/ml as a cut-off was found to discriminate quite wel-i between children with no re-:,or-_ed ETS exposure at home and those with some exposure. The main finding of the study was that there was a trend towards increas.ng number of ex acerbat ions of asthma and decreasing lung function with increas-ns ETS ex?osure whether one used parental reports or urinary cotinine. The increased risk of asthma exacerna:--ons was significanz after adjustment for maternal age and educacion level and the child's age, sex and day-care attendance, with children in the highest exposure group (mother and others smoke or >39 ng/ml urinary cotinine) having almost twice (1.8 and 1.7 respectively) the number of exacerbations of the lowest exposure group (no reported smoking a= home or <10 ng/ml urinary coz-nine). Although the corresponding reductions in forced expiratory volume in one second (FEV 1 ) were not quite statistically significant. significant reductions were seen for forced expiratory flow between 25% and 75% of vital capacity (FEF 25-75! ) and in FEV 1 adjusted ital capac~ty (FVC). for forced Serum theophylline levels were found to be similar in children prescribed tz:heophylline and exposed to smoke in the home and in children prescribed theophylline and not ETS exposed, suggesting that the two 0 groups of children followed medical advice similarly. CD CD Co CI% Co BATCo document for Legal Services: Health Canada 19 October 1999 The authors em--*-as--ze ::*.-.e value of usinz urine cotinine levels as a marker of ETS ex-;:-=--re and conclude that t*-el-r s=udy "provides further evidence of an association between exposure to environmental tobacco smoke and pulmona:-- morbidi a' -:-.- in children with asthm I , and that their data "emphasize the need for systematic, persistent efforts to stop the exposure of children with as~*--=ta to environmental tobacco smoke". While the stud-.- '" qu--~e a reasonable one, it does have some limitations. Inter alia. (a) No data have tcen col--ac-ced on presence of respiratory disease in the parents or other ho--sehold members, so that the possibility of the association arising from cross- inf ection cannot be ruled out; (b) No data have been collected on smoking by the mother in pregnancy, so that possi7.-'-z- eff"ects of in utero and in Miyc exposure to tobacco smoke constitua-nzs cannoz be ruled out; (c) No data have been COlleczad on exposure to various allergens; and (d) Although data -;cere collected on severity of the underlying disease, no attempt was made to zake this into account in analysis. Did the children in the more E--S exposed group have more attacks because they were exposed more, or because they had more severe disease on average to sta=:: with? Despite these limitations, it is clear that the evidence relating to ETS and asthma dema7---s careful attention. It should be pointed out that not all studies have reported a relationship. For example, see the recent (Jri CD CD (DZ CI\ Cc BATCo document for Legal Services: Health Canada 19 October 1999 letter by Platts-Mills and Call (also attached) in the Journal of Pediatrics. A caref-.:'-- review is req--~-red. A recenzly published review by Ehrlich of the overall evidence is considered in my next review (673). F N Lee 15.11.93 40 0 C'il CD CD CD (31% cc BATCo document for Legal Services : Health Canada 19 October 1999